⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Effect of Oral Nutritional Supplements on Body Weight Loss of Patients With Nasopharyngeal Carcinoma

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Effect of Oral Nutritional Supplements on Body Weight Loss of Patients With Nasopharyngeal Carcinoma

Official Title: Effect of Oral Nutritional Supplements From the Beginning of Radiotherapy on Body Weight Loss of Patients With Nasopharyngeal Carcinoma and Its Cost-Utility Analysis: A Prospective Multicenter Randomized Controlled Trial

Study ID: NCT04823468

Study Description

Brief Summary: Concurrent chemoradiotherapy(CCRT) is the principal treatment for nasopharyngeal carcinoma(NPC). Studies have shown that malnutrition is very common in patients with NPC after chemoradiotherapy. Malnutrition can lead to weight loss, treatment interruption, prolonged stay in hospital, increased treatment costs, reduced tolerance to anti-tumor therapy, reduced quality of life and shortened survival time. Nutritional intervention can improve the nutritional status, reduce treatment-related toxicity and improve the survival of patients with NPC. The first choice of nutritional intervention is oral nutritional supplements(ONS). Some retrospective studies with small samples have found that early nutritional intervention can reduce weight loss and severe oral mucositis in patients with NPC, compared with late nutritional intervention. Therefore, the investigators proposed the hypothesis that ONS from the beginning of radiotherapy can reduce the nutritional impairment, treatment-related toxicity and treatment costs of patients with NPC, and improve their quality of life. The aim of this multicenter randomized controlled clinical trial is to evaluate the efficacy and cost utility of ONS from the beginning to the end of radiotherapy.

Detailed Description:

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Fujian Medical University Union Hospital, Fuzhou, Fujian, China

First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China

Fujian Cancer Hospital, Fuzhou, Fujian, China

900th hospital of the joint logistics team, PLA, Fuzhou, Fujian, China

The Nanping First Affiliated Hospital of Fujian Medical University, Nanping, Fujian, China

Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, Fujian, China

The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, China

The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China

Zhongshan Hospital Xiamen University, Xiamen, Fujian, China

Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou, Fujian, China

Nanfang Hospital of Southern Medical University, Guangzhou, Guangdong, China

Hunan Cancer Hospital, Changsha, Hunan, China

Jiangxi Provincial Cancer Hospital, Nanchang, Jiangxi, China

Contact Details

Name: Jinsheng Hong

Affiliation: First Affiliated Hospital of Fujian Medical University

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: